Nicholas McKeehan (@nmckeehan) header
Nicholas McKeehan (@nmckeehan) profile picture
Queens, NY
Joined June 2011
Here is our first paper about levels of sulfated steroid hormones and #aging. An excellent example of how basic research from @CABD_UPO_CSIC leads us to the discovery of a promising #Alzheimer’s treatment @OlavideNeuSTX. Now in @NatureComms (1/5). ➡️nature.com/articles/s41467-0…
10
29
13
64
Nicholas McKeehan retweeted
FDA panel vote on whether Biogen's Study 302 (its positive study) provides strong evidence supporting the effectiveness of aducanumab for the treatment of Alzheimer's disease: Yes: 1 No: 8 Uncertain: 2
15
60
20
133
Nicholas McKeehan retweeted
My mum just reminded me of the time I tried to take on Big Pharma when I was 5.
126
5,502
192
24,600
Nicholas McKeehan retweeted
Seriously disappointing news. First big nail in the coffin of the “AD drugs haven’t worked because we didn’t give them early enough” hypothesis. Need to see fuller data and to try to understand if had enough power to realistically see disease slowing. But a bad start to the week.
Top line results from DIANTU negative. Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates – Washington University School of Medicine in St. Louis medicine.wustl.edu/news/alzh…
2
33
1
52
Nicholas McKeehan retweeted
$RHHBY Roche announced that the gantenerumab arm of the Ph 2/3 DIAN-TU-001 study didn't meet its primary endpoint in patients with autosomal dominant #Alzheimers disease. #Fail $LLY Roches claims results don't impact the other Ph 3 trials in common AD. roche.com/media/releases/med…
1
4
Nicholas McKeehan retweeted
What's wrong with this picture? We desperately need to increase investment in the #NeglectedCommonDiseases such as cardiovascular disease. Credit: BIO Industry Analysis, David Thomas / Chad Wessel
12
64
17
180
Nicholas McKeehan retweeted
Review of lysosomes as a therapeutic target from @NatRevDrugDisc: nature.com/articles/s41573-0… They are implicated in LSDs, lupus, rheumatoid arthritis, #MultipleSclerosis #Alzheimers & #Parkinsons $SNY $SHPG $TAK $PFE $BMRN $RARE $ALXN $JNJ $IDRSF $IVA $FOLD $RHHBY $GSK $IMM $EIGR
1
2
10
Hats off to @AkiliLabs for running a RCT. Gathering Clinical data in the digital Tx space is, sadly, not a common thing to see. Hopefully, all of us can follow going through the same clinical path so as to make better & more efficient treatments to pts. Well done
2
3
5
Nicholas McKeehan retweeted
Today: "The Patient-Scientist's Mandate" — how the work we do to develop a drug for prion disease is informed by Sonia's perspective as a patient at risk. There are 3 ways that we sometimes diverge from other scientists.
3
70
6
149
Nicholas McKeehan retweeted
Interesting commentary on the aducanumab story, and the forces potentially in play with FDA approval, in Harry Tracy’s NeuroPerspective. Sorry about the image quality, but beautifully written and worth a read.
9
2
22
Nicholas McKeehan retweeted
Good perspective from @sciencemagazine on bypassing the blood-brain barrier. The meninges have been identified as "backdoors" to the BBB and could enable CNS penetration. Exploring meningeal routes could provide promising therapeutic targets. Article: science.sciencemag.org/conte…
1
6
1
16
Nicholas McKeehan retweeted
Point of care biosensor diagnostics for NAD+ @CharlesMBrenner @NatMetabolism nature.com/articles/s42255-0…
3
1
12
Nicholas McKeehan retweeted
$ALEC R&D Day Highlights: - AL001 Ph 1b, FTD-GRN showed normalization in disease-associated proteins & decrease in NfL levels - AL002 Ph 1 showed target engagement & proof-of-mechanism - AL003 Ph 1 showed dose dependent & long-lasting target engagement investors.alector.com/news-r…
1
5
Nicholas McKeehan retweeted
– at San Diego, CA
36
260
51
1,589
Nicholas McKeehan retweeted
Answer: an LRP5 gain of function was discovered in an individual that survived a car crash with no fractures due to denser bones which is similar to the story of Bruce Willis character in Unbreakable.
3
5
Nicholas McKeehan retweeted
Alzforum list 187 models on its excellent website, and offers an in-depth comparison of their phenotypic characteristics: alzforum.org/research-models…
1
1
2
Nicholas McKeehan retweeted
Another well written aducanumab data critique from the physician side of things, this one from @LonSchneiderMD in Lancet Neurology. Good to see my math on the CDR-SB numerical benefit wasn't wrong. els-jbs-prod-cdn.literatumon…
2
13
2
30
Nicholas McKeehan retweeted
Interesting JPAD editorial from F Sierra, N.I.A on targeting Aging for Alzheimer prevention and drug discovery just before the CTAD conference San Diego #Gerosciences #aging #CTAD #Alzheimer
GEROSCIENCE AND THE ROLE OF AGING IN THE ETIOLOGY AND MANAGEMENT OF ALZHEIMER’S DISEASE. F. Sierra jpreventionalzheimer.com/cur…
10
4